Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Potential New Lupus Treatment Effectively Reduced Disease Activity in Trial

americanpharmaceuticalreviewSeptember 03, 2019

Tag: lupus , Treatment , TULIP 2 , Anifrolumab

PharmaSources Customer Service